Avricore Health (AVCRF) Gross Profit (2009 - 2026)

Avricore Health (AVCRF) has reported Gross Profit for 16 consecutive years, with -$6202.7 the latest figure, recorded in Q2 2026.

• In Q2 2026, Gross Profit rose 82.13% year-over-year to -$6202.7; the TTM figure through Jun 2026 stood at -$84374.2 (down 104.72% YoY), while the FY2025 annual figure was $170552.8, down 87.58% from the prior year.
• Gross Profit fell to -$6202.7 in Q2 2026 per AVCRF's latest filing, from -$5239.7 in the prior quarter.
• Across five years, Gross Profit topped out at $948958.9 in Q3 2024 and bottomed at -$38221.0 in Q3 2025.
• Historically, Gross Profit has averaged $208000.6 across 5 years, with a median of $160713.6 in 2022.
• Annual changes were most pronounced in 2022 — Gross Profit jumped 5594.34% — and 2025, when it plunged 105.51%.
• Avricore Health's Gross Profit stood at $124388.6 in 2022, then surged by 196.12% to $368344.6 in 2023, then soared by 157.63% to $948958.9 in 2024, then slumped by 100.55% to -$5239.7 in 2025, then dropped by 18.38% to -$6202.7 in 2026.
• Business Quant data shows AVCRF's Gross Profit at -$6202.7 in Q2 2026, -$5239.7 in Q4 2025, and -$38221.0 in Q3 2025.